4Kantor PF,Lucien A,Kozak R,et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain3-ketoacyl coenzyme A thiolase[J]. Circ Res, 2000,86(5 ) : 580-588.
5Eugene B,Elliott M,John W,et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction :executive summary and recommendtions [J]. Circulation, 2000,102 ( 5 ) : 1193 - 1209.
6Birand A,kudaiberdieva GZ,β atyralier TA et al.Effects of trimetazidine on heart rate Variability and left ventricular sytolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty.Angiology,1997,48(5):413
7Farrari,Popi P,Farrari F et al.Metabolic derangement in ischemic heart disease and its therapeutic control.Am J Cardiol,1998,92:2
8Detry JM,Lecler eg PJ.TEMS studg.Trimetazidine vs prapranalol in patients with stable angina pectoris:contribu tion of electrie cardiogram monitoring.Am J Cardiol,1995,76:8
9Kay L.Improvement of long-term preservation of the isolated arrested rat heart by trimetazidine:Effects on the energy state and mitochondrial function.Am J Cardiol,1995,76:45
10Lery S.Combination therapy of trimtazidine with diltiazem in patients with coranary artery disease,group of south of frabce iuvestigators.Am J Cardiol,1995,76(6):12
